Home
About
Overview
Sharing Data
ORCID
Help
History (5)
[Usefulness of routine electron-microscopic studies in the diagnosis of malignant lymphoma].
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
Iliac arteriovenous fistulas after lumbar spinal surgery.
The effect of red blood cell transfusion on fatigability after hospital discharge.
The Pediatrician's Moral Obligation to Counsel Directively Against Youth Tackle Football.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
View in:
PubMed
subject areas
Anemia
B-Cell Maturation Antigen
Humans
Immunotherapy, Adoptive
Multiple Myeloma
T-Lymphocytes
authors with profiles
Andrzej Jakubowiak